Rituximab in combination with vinorelbine/gemcitabine chemotherapy in patients with primary refractory or early relapsed T cell rich B cell lymphoma - A pilot study

By Xiros N.   Economopoulos T.   Valsami S.   Rontogianni D.   Fountzilas G.   Raptis S.  

Leukemia Research, Vol. 27, Iss. 12, 2003-12 ,pp. : 1097-1099

Elsevier

Access to resources Recommend Favorite

Long-term remission in a patient with refractory thrombotic thrombocytopenic purpura treated with rituximab and plasma exchange

By Basquiera A.  

Annals of Hematology, Vol. 87, Iss. 4, 2008-04 ,pp. : 321-323

Springer Publishing Company

Access to resources Recommend Favorite

Tandem myeloablative ¹³¹I-rituximab radioimmunotherapy and high-dose chemotherapy in refractory/relapsed non-Hodgkin lymphoma patients

By Deshayes Emmanuel   Kraeber-Bodéré Françoise   Vuillez Jean-Philippe   Bardiès Manuel   Teulon Isabelle   Pouget Jean-Pierre  

Immunotherapy, Vol. 5, Iss. 12, 2013-12 ,pp. : 1283-1286

Future Medicine

Access to resources Recommend Favorite

The effectiveness of lamivudine in preventing hepatitis B viral reactivation in rituximab-containing regimen for lymphoma

By He Yi-Fu  

Annals of Hematology, Vol. 87, Iss. 6, 2008-06 ,pp. : 481-485

Springer Publishing Company

Access to resources Recommend Favorite

Primary cardiac onset of disseminated Burkitt’s lymphoma

By Stefani Piero  

Annals of Hematology, Vol. 87, Iss. 6, 2008-06 ,pp. : 487-488

Springer Publishing Company

Access to resources Recommend Favorite